White Marsh, MD, United States of America

Niranjan B Pandey

USPTO Granted Patents = 14 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

Flemington, NJ (US) (2009 - 2010)
Baltimore, MD (US) (2023)
White Marsh, MD (US) (2008 - 2024)

Company Filing History:

8 out of 3,682

The Johns Hopkins University

patents

4 out of 2,076

Janssen Pharmaceutica Nv

patents

2 out of 16

Alba Therapeutics Corporation

patents

4. 1 out of 1

Asclepix Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11981754 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2024-05-14),

2. 11674959 - Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors (2023-06-13),

3. 11155603 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases (2021-10-26),

4. 10774131 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases (2020-09-15),

5. 10774112 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2020-09-15),

6. 10106597 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases (2018-10-23),

7. 9802984 - Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases (2017-10-31),

8. 9056923 - Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases (2015-06-16),

9. 8796203 - Use of tight junction antagonists to treat inflammatory bowel disease (2014-08-05),

10. 8299017 - Use of tight junction antagonists to treat inflammatory bowl disease (2012-10-30),

11. 7659284 - Thiazolopyridine kinase inhibitors (2010-02-09),

12. 7605154 - Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors (2009-10-20),

13. 7579356 - Thia-tetraazaacenaphthylene kinase inhibitors (2009-08-25),

14. 7427625 - Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors (2008-09-23),

Title: Innovations of Niranjan B Pandey

Introduction

Niranjan B Pandey is a prominent inventor based in White Marsh, MD (US), known for his significant contributions to the field of biomedical research. With a total of 14 patents to his name, he has made remarkable strides in developing innovative solutions for treating various diseases.

Latest Patents

Among his latest patents, Niranjan has developed a biomimetic peptide and biodegradable delivery platform aimed at treating angiogenesis- and lymphangiogenesis-dependent diseases. This includes mimetic peptides that possess anti-angiogenic and anti-tumorigenic properties, which are crucial for addressing conditions such as cancer and ocular diseases like age-related macular degeneration. One of his notable inventions features an isolated peptide with the amino acid sequence LRRFSTAPFAFIDINDVINF, demonstrating anti-angiogenic activity in various assays. Additionally, he has created methods for identifying and preparing pharmaceutical agents that activate Tie1 and/or Tie2 receptors, which are essential for addressing disorders related to abnormal vascularization.

Career Highlights

Niranjan has worked with esteemed organizations such as The Johns Hopkins University and Janssen Pharmaceutica NV. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Aleksander S Popel and Amir P Tamiz, who have played significant roles in his research endeavors.

Conclusion

Niranjan B Pandey's innovative work in the biomedical field showcases his dedication to advancing medical science through his patents and collaborations. His contributions are paving the way for new treatments that could significantly impact patient care.

This text is generated by artificial intelligence and may not be accurate.